BREAKING

Bitcoin Steadies at $77,000: What Investors Should Know · RBI Dividend Offers Buffer Amid Inflation Risks: Insights · Nvidia CEO Reflects on Struggles in Building Tech Giant · Nvidia CEO Jensen Huang Reflects on Tough Journey · Global Market Outlook: Key Risks for Investors Today

CRITICAL RISK · FINANCE

FDA Accelerates Psychedelic Drug Research After Trump Order

📰 CNBC Finance · Apr 24, 2026 at 1:09 PM · Risk Score: 36 · Triggers: depression, war

⚠️ CRITICAL RISK NEWS Score: 36
Updated: TODAY | Source: CNBC Finance | Read time: 3 min

📌 In One Sentence:

The FDA’s recent decision to fast-track research into psychedelic drugs signals a significant shift towards supporting their use in treating mental health conditions like depression and PTSD.

← Back to FinCris

Intelligence Assisted Content · ⚠️ Not Financial Advice · Consult a SEBI Registered Advisor